The Journal of Experimental Medicine
AbD Serotec: www.ab-direct.com/4for3
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 31 December 2001. doi:10.1084/jem.20011341
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Menges, M.
Right arrow Articles by Lutz, M. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Menges, M.
Right arrow Articles by Lutz, M. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© Rockefeller University Press, 0022-1007/2002/1/15/ $5.00
The Journal of Experimental Medicine, Volume 195, Number 1, January 7, 2002 15-22


Original Article

Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor {alpha} Induce Antigen-specific Protection of Mice from Autoimmunity

Mauritius Menges1, Susanne Rößner1, Constanze Voigtländer1, Heike Schindler2, Nicole A. Kukutsch1, Christian Bogdan2, Klaus Erb3, Gerold Schuler1 and Manfred B. Lutz1

1 Department of Dermatology, Immunology and Hygiene, University of Erlangen, Erlangen 91052, Germany
2 Institute for Microbiology, Immunology and Hygiene, University of Erlangen, Erlangen 91052, Germany
3 Center for Infection Research, University of Würzburg, Würzburg 97070, Germany

Address correspondence to M.B. Lutz, Department of Dermatology, Hartmannstrasse 14, University of Erlangen, Erlangen 91052, Germany. Phone: 49-9131-853-6307; Fax: 49-9131-853-6336; E-mail: lutz{at}derma.imed.uni-erlangen.de

Mature dendritic cells (DCs) are believed to induce T cell immunity, whereas immature DCs induce T cell tolerance. Here we describe that injections of DCs matured with tumor necrosis factor (TNF)-{alpha} (TNF/DCs) induce antigen-specific protection from experimental autoimmune encephalomyelitis (EAE) in mice. Maturation by TNF-{alpha} induced high levels of major histocompatibility complex class II and costimulatory molecules on DCs, but they remained weak producers of proinflammatory cytokines. One injection of such TNF/DCs pulsed with auto-antigenic peptide ameliorated the disease score of EAE. This could not be observed with immature DCs or DCs matured with lipopolysaccharide (LPS) plus anti-CD40. Three consecutive injections of peptide-pulsed TNF/DCs derived from wild-type led to the induction of peptide-specific predominantly interleukin (IL)-10–producing CD4+ T cells and complete protection from EAE. Blocking of IL-10 in vivo could only partially restore the susceptibility to EAE, suggesting an important but not exclusive role of IL-10 for EAE prevention. Notably, the protection was peptide specific, as TNF/DCs pulsed with unrelated peptide could not prevent EAE. In conclusion, this study describes that stimulation by TNF-{alpha} results in incompletely matured DCs (semi-mature DCs) which induce peptide-specific IL-10–producing T cells in vivo and prevent EAE.

Key Words: dendritic cells • EAE • tolerance • IL-10 • TNF


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS